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 The focus on acute, episodic care in the conventional health-care model fails 
to provide adequately for changing health-care needs arising from increased 
longevity and increasing prevalence of chronic disease. Integrated care 
involves coherent and co-ordinated delivery of health-care services across a 
broad range of health and social care providers. A principal aim of integrated 
health care is to improve the patient’s journey through the system by co-
ordinating care among providers and by strengthening the role of primary 
care. Effective resource allocation mechanisms, supported by appropriate 
financing arrangements, have an important role to play in delivering integrated 
health care. In addition, more efficient use of scarce health-care resources is 
required, and can be influenced by the resource allocation and financing 
mechanisms. This article summarises research undertaken by the ESRI to 
provide evidence for the Expert Group on Resource Allocation and Financing 
in Health Care, which reported in July 2010 (Brick et al., 2010a, b; Ruane, 
2010). The research: 
Introduction 
 
• reviewed the theoretical and international empirical literature on resource 
allocation, financing and sustainability in health care (focusing on eight 
comparator countries – Australia, Canada, Germany, Netherlands, New 
Zealand, Sweden, UK, USA); 
• evaluated current Irish systems of resource allocation and financing and 
issues associated with sustainability;  
• proposed a framework for health-care entitlements and user fees that 
would support the delivery of integrated health care in Ireland. 
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It is important to provide an overview of trends in the overall level of 
resources available for health, and the drivers of increased health-care 
expenditure. Since 2000, Irish public health expenditure has more than 
doubled in real terms to reach a level of over €15bn in 2009. It accounted for 
almost 12 per cent of national income in 2009, up from 6.3 per cent in 2000. 
Health care accounted for about one in every four euros of total public 
expenditure throughout the last decade. Concerns about sustainability are not 
unique to Ireland; total per capita expenditure on health increased by an 
average of 6.4 per cent per annum across the EU‐15, Australia, Canada, New 
Zealand and the US over the period 2000-2007. 
Sustainability 
 
Several studies have found that national income is the single most 
important driver of public health expenditure, with increases in income 
leading to proportionately equal increases in health expenditure. Other 
important factors include demographic change and an increasing burden of 
chronic disease, as well as supply‐side factors such as rising medical prices, 
technological change, increasing capital stock and labour costs, the regulatory 
regime governing behaviour in the health sector and the incentive structure 
facing health‐care providers are also important. In Ireland, while the size of 
the population increased by 17.7 per cent over the period 2000‐2009, the share 
of the population aged over 65 years actually declined slightly over the period. 
The growth in national income was much more substantial, as was the change 
in both the overall price level and the change in health prices.  
 
Particular concern over sustainability has arisen with regard to state 
expenditure on pharmaceuticals and payments to pharmacists. Approximately 
85 per cent of total expenditure on pharmaceuticals in Ireland relates to state 
expenditure on pharmaceuticals and payments to pharmacists under the 
General Medical Service (GMS) Scheme and community drugs schemes 
(CDS). Expenditure on the GMS Scheme alone has increased from €831m in 
2005 to €1.3bn in 2009 (195 per cent in real terms). The growth can be 
explained by a combination of increases in the price (e.g. newer, more 
expensive drugs) and volume (e.g. increase in eligibility) of drugs prescribed. 
Recent attempts to control this expenditure have focused largely on two 
particular measures, namely, attempting to secure better value for money via 
amendments to the pricing and reimbursement mechanisms on the GMS and 
CDS, and increasing the degree of cost sharing on the part of patients. 
 
 Internationally, the concept of population health need is being used to 
allocate health-care resources, in contrast to traditional methods driven by 
historic allocations to existing providers and facilities. In Ireland, resources are 
allocated largely on an historic funding basis, notwithstanding recent attempts 
to move to a more rational allocation of resources for some services (e.g. 
services for older persons). 
Resource 
Allocation 
 
Even when allocations are made on the basis of population health, the 
extent of ‘purchaser-provider split’ and methods of provider reimbursement 
can have important implications for the degree to which providers are 
financially incentivised to deliver appropriately integrated health care. One of 
the main advantages of segregating the purchasing and providing functions is 
the ability to employ financial incentives and monitoring tools to encourage 
providers to offer services more efficiently. While there is strict separation 
between the purchaser and provider in many aspects of Irish health care (e.g. 
between the HSE and GPs), other relationships are not characterised by such 
a split (e.g. the HSE owns and funds more than half of acute public hospitals).  
Provider reimbursement can be activity-based (e.g. per number of 
patients/cases treated, treatment intensity or duration). This method could 
stimulate activity, but may be less effective at controlling costs than other 
reimbursement systems (such as global budgets or fixed salaries). The 
consensus which emerges from research is that no single payment mechanism 
can achieve all of the stated health-care objectives; rather, a mix of 
reimbursement types is required.  
 
For the remuneration of GPs, most countries use a mixture of capitation 
and fee-for-service remuneration, with salary payments less common. Many 
countries are also now experimenting with pay-for-performance elements, 
whereby GPs face financial incentives for chronic disease management, 
appropriate prescribing, data collection, etc. The Irish system is unusual in that 
methods of GP remuneration depend on patient type; predominately 
capitation for medical card patients, and fee-for-service for private patients. 
The conflicting incentives on the part of GPs that arise from this distinction 
do not facilitate the delivery of integrated health care. 
 
Casemix funding (prospective, activity-based payments) is now the 
preferred hospital reimbursement mechanism in six of the eight countries 
studied. Despite some common objectives for casemix funding, 
implementation varies considerably across countries, making it difficult to 
evaluate the system’s impacts on activity, length of stay, quality and costs. For 
treating public patients, Irish public hospitals receive budgetary allocations, 
predominantly determined by historic factors. A subset of hospitals receives a 
retrospective budgetary adjustment for treatment complexity and relative 
performance. The planned move to prospective casemix funding should 
improve the transparency between payment and activity. Of some concern are 
potential perverse (and conflicting) incentives generated by the different 
mechanisms used to reimburse Irish public hospitals and their consultants for 
public and private patients (e.g. consultants in public hospitals receive a salary 
for treating public patients but a fee-for-service for private practice). 
 
Crucial for integrated care is the alignment of financial incentives not only 
within, but also between, all sectors of the health-care system. Many 
international initiatives have sought to improve integration; however, these 
schemes generally fail to co-ordinate care across multiple conditions and lack 
formal evaluation. In Ireland, the HSE established the Integrated Services 
Directorate in 2009. While necessary, such organisational reforms are not 
sufficient for integration. Further development of primary care in particular is 
required, as well as financial incentives that are consistent across providers and 
patients. 
 
 Without resources, there is nothing to allocate. How resources are 
generated can affect the resource allocation process. In Europe, the main 
health care financing sources include public taxation, social health insurance, 
private health insurance and out-of-pocket payments. In Ireland, public taxes 
account for the largest proportion of health care financing (approximately 80 
per cent) followed by out-of-pocket payments and private health insurance. 
Health systems are often grouped according to the dominant source of 
financing (e.g. tax-based systems). However, as the mix of health resource 
mechanisms is becoming more complex, it is more logical to assess the merits 
or otherwise of each individual mechanism separately. 
Financing 
 
Tax and social health insurance contributions both introduce separation 
between what people pay for health care, and what they receive. This allows 
the principles for collecting resources from individuals (e.g. according to 
ability to pay) to be separate from the principles determining how those 
resources are allocated (i.e. population health need). With social health 
insurance there is a clear, observable link between available health-care 
resources and health-care entitlements; although this transparency can be 
reduced where social health insurance is supplemented by tax-based resources. 
International evidence indicates that there are ways of introducing many of the 
desired features of social health insurance in a tax-based system. In the Irish 
context, policy-makers need to address problems of poor transparency around 
public tax-based resources, in particular the complications associated with 
public subsidisation of private health care activity.  
 
Out-of-pocket payments are directly linked with the individual’s use of the 
service. These payments are outside the public resource allocation process. 
International evidence indicates that user fees discourage both necessary and 
unnecessary utilisation, and have negative implications for equity and there is 
evidence of this in Ireland. The requirement for non medical cardholders, the 
majority of the population, to pay out-of-pocket for GP care is unique to 
Ireland compared with other developed countries. An inconsistent structure 
of user fees across community, primary and acute care means that non 
medical cardholders are not always directed to the most appropriate location 
for their care. These features interrupt the delivery of integrated health care. 
Incentives facing patients and providers need to be aligned so as to ensure 
that health problems are diagnosed at the earliest opportunity, that there is 
continuity of care for people with chronic conditions and that the most 
appropriate care takes place in the most appropriate location.  
 
To support this process, a coherent framework of entitlements and user 
fees is proposed. Within the framework, a set of graduated subsidies are 
available for GP care, prescription medicines and other care for the whole 
population (people on lower incomes would receive higher levels of subsidy). 
Subsidisation of chronic conditions would also be streamlined to address 
existing inconsistencies (e.g. exclusion of certain critical conditions from the 
Long-Term Illness Scheme). The framework removes the large jumps in 
entitlement that are currently in place (e.g., where income increases above the 
GP Visit medical card eligibility threshold, the user fee for GP care increases 
from zero to the full private charge). The framework also introduces greater 
separation between payment for health care and people’s risk of ill health by 
reducing the extent to which health care is paid for at the point of use. 
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